NewGenIvf Days Sales Outstanding from 2010 to 2025

NIVFW Stock   0.03  0.01  30.96%   
NewGenIvf Group Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding will most likely to outpace its overall moving average this year. During the period from 2010 to 2025, NewGenIvf Group Days Sales Outstanding regression line of quarterly data had mean square error of  350.20 and geometric mean of  70.96. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
72.56347698
Current Value
75.14
Quarterly Volatility
19.58144722
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NewGenIvf Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewGenIvf Group's main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 75.14. NewGenIvf financial statements analysis is a perfect complement when working with NewGenIvf Group Valuation or Volatility modules.
  
Check out the analysis of NewGenIvf Group Correlation against competitors.

Latest NewGenIvf Group's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of NewGenIvf Group Limited over the last few years. It is NewGenIvf Group's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewGenIvf Group's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

NewGenIvf Days Sales Outstanding Regression Statistics

Arithmetic Mean72.57
Geometric Mean70.96
Coefficient Of Variation26.98
Mean Deviation9.70
Median66.51
Standard Deviation19.58
Sample Variance383.43
Range76.2081
R-Value0.39
Mean Square Error350.20
R-Squared0.15
Significance0.15
Slope1.71
Total Sum of Squares5,368

NewGenIvf Days Sales Outstanding History

2024 75.14
2023 72.56
2022 142.71

About NewGenIvf Group Financial Statements

NewGenIvf Group investors use historical fundamental indicators, such as NewGenIvf Group's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NewGenIvf Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 72.56  75.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NewGenIvf Stock Analysis

When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.